The AI-powered research platform promises to automate the entire scientific discovery loop, from hypothesis to experiment, and could reshape how biotech and pharma companies allocate R&D budgets.
Microsoft just made its biggest play yet to become the operating system for scientific research. Microsoft Discovery, an AI platform designed to let researchers build, orchestrate, and run entire experimental workflows using multi-agent AI systems, became generally available on June 2.
The marquee partnership here is with Ginkgo Bioworks, the synthetic biology company whose automated lab infrastructure will plug directly into Microsoft’s platform. Researchers can now design experiments inside Microsoft Discovery and execute them on Ginkgo’s Cloud Lab without ever touching a pipette.
What Microsoft Discovery actually does #
The platform handles what Microsoft calls the “entire discovery loop.” That means evidence gathering, hypothesis formulation, experimentation, and iterative analysis, all coordinated by AI agents. There are specific agents for dataset analysis, hypothesis generation, simulation, and validation.
The platform targets a wide range of disciplines. Biology, chemistry, materials science, and pharmaceuticals are all supported.
Microsoft also introduced a Discovery app designed for desktop and local use, aimed at individual researchers and small teams.
The platform went through a private preview at Microsoft Build 2025, followed by an expanded preview in April 2026. During that preview period, collaborators included Yale Engineering, Georgia Tech, and Pacific Northwest National Laboratory.
The Ginkgo Bioworks connection #
The Ginkgo partnership connects Ginkgo’s autonomous laboratory infrastructure to Microsoft’s AI orchestration layer, creating a system where an AI agent can hypothesize, design an experiment, run it in an automated lab, and analyze the results in a closed loop.
“Together, agentic AI and autonomous labs will change every part of the scientific process,” said Ginkgo Bioworks CEO Jason Kelly.
By off execution to Ginkgo’s Cloud Lab, Microsoft Discovery removes a key bottleneck in pre-clinical biological research. Researchers can get faster, more reproducible results without maintaining their own physical automation systems.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our